Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut
18/06/2025 17:31
June 18 (Reuters) - Caris Life Sciences' CAI.O shares jumped nearly 28.6% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025. (Reporting by Pritam Biswas in Bengaluru; Editing by Shinjini Ganguli) ((Pritam.Biswas@thomsonreuters.com;))
Recent news on Caris Life Sciences
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Caris Life Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services